5 Stock Setups Where Wall Street Sees the Most Upside Right Now

Impact · against what's priced in

The report identifies significant upside potential for specialized industrial and healthcare plays, most notably CECO and PRM, driven by AI infrastructure demand and monopoly positioning. While these firms show strong momentum, the most material catalysts are the transformative acquisitions of Thermon and MMT, and the expansion of royalty assets for Ligand.

CECO+0.80: No priced-in read yet

5 Stock Setups Where Wall Street Sees the Most Upside Right Now

What matters in this story

Insmed: A Blockbuster Launch, Priced Ahead Of Its Own Guidance

5 Stock Setups Where Wall Street Sees the Most Upside Right Now

What matters in this story

Insmed: A Blockbuster Launch, Priced Ahead Of Its Own Guidance

How each ticker is affected

Connected tickers

Track these names every morning.

Palantir: Great Business, Wrong Time (Rating Downgrade)

Gilead Pays a $3.28 Annual Dividend Despite Negative Earnings. Is It Safe?

What Global Net Lease (GNL) Said on Its Q3 Earnings Call

W.W. Grainger: AI Demand Adds Momentum, But Valuation Leaves Little Room For Error

5 Stock Setups Where Wall Street Sees the Most Upside Right Now

What matters in this story

Next reads from the same story arc

Insmed: A Blockbuster Launch, Priced Ahead Of Its Own Guidance

5 Stock Setups Where Wall Street Sees the Most Upside Right Now

What matters in this story

Next reads from the same story arc

Insmed: A Blockbuster Launch, Priced Ahead Of Its Own Guidance

How each ticker is affected

Connected tickers

Track these names every morning.

Palantir: Great Business, Wrong Time (Rating Downgrade)

Gilead Pays a $3.28 Annual Dividend Despite Negative Earnings. Is It Safe?

What Global Net Lease (GNL) Said on Its Q3 Earnings Call

W.W. Grainger: AI Demand Adds Momentum, But Valuation Leaves Little Room For Error